FDA inspection
Jiangsu Hansoh Pharmaceutical Group Co., Ltd: FDA inspection ending Apr 24, 2026
FDA inspection 1315768 · Official Action Indicated (OAI) · Lianyungang
Key facts
| Inspection ID | 1315768 |
|---|---|
| Firm | Jiangsu Hansoh Pharmaceutical Group Co., Ltd |
| FEI number | 3008316144 |
| Address | Economic & Technical, 5 Dongjin Road; Dev. Zone |
| City | Lianyungang |
| Country | China |
| Fiscal year | 2026 |
| Inspection end date | Apr 24, 2026 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data